These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7912625)

  • 1. Insulin requirement for the antihyperglycaemic effect of metformin.
    Bailey CJ; Mynett KJ
    Br J Pharmacol; 1994 Mar; 111(3):793-6. PubMed ID: 7912625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose-lowering effect of BTS 67 582.
    Page T; Bailey CJ
    Br J Pharmacol; 1997 Dec; 122(7):1464-8. PubMed ID: 9421296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stevioside induces antihyperglycaemic, insulinotropic and glucagonostatic effects in vivo: studies in the diabetic Goto-Kakizaki (GK) rats.
    Jeppesen PB; Gregersen S; Alstrup KK; Hermansen K
    Phytomedicine; 2002 Jan; 9(1):9-14. PubMed ID: 11924770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin improves immunosuppressant induced hyperglycemia and exocrine apoptosis in rats.
    Shivaswamy V; Bennett RG; Clure CC; Larsen JL; Hamel FG
    Transplantation; 2013 Jan; 95(2):280-4. PubMed ID: 23250335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of metformin on the vascular and glucose metabolic actions of insulin in hypertensive rats.
    Santuré M; Pitre M; Gaudreault N; Marette A; Nadeau A; Bachelard H
    Am J Physiol Gastrointest Liver Physiol; 2000 May; 278(5):G682-92. PubMed ID: 10801260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of intravenous metformin on glucose metabolism during hyperglycaemia in type 2 diabetes.
    Sum CF; Webster JM; Johnson AB; Catalano C; Cooper BG; Taylor R
    Diabet Med; 1992; 9(1):61-5. PubMed ID: 1551312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose effectiveness is the major determinant of intravenous glucose tolerance in the rat.
    McArthur MD; You D; Klapstein K; Finegood DT
    Am J Physiol; 1999 Apr; 276(4):E739-46. PubMed ID: 10198311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoglycemic effects of peroxovanadium compounds in Sprague-Dawley and diabetic BB rats.
    Yale JF; Lachance D; Bevan AP; Vigeant C; Shaver A; Posner BI
    Diabetes; 1995 Nov; 44(11):1274-9. PubMed ID: 7589823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of the intestine as a site of metformin-stimulated glucose utilization.
    Bailey CJ; Mynett KJ; Page T
    Br J Pharmacol; 1994 Jun; 112(2):671-5. PubMed ID: 8075887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential antidiabetic activity of some alpha-2 adrenoceptor antagonists.
    Abdel-Zaher AO; Ahmed IT; El-Koussi AD
    Pharmacol Res; 2001 Nov; 44(5):397-409. PubMed ID: 11712871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of somatostatin on carbohydrate disposal and absorption in diabetes mellitus.
    Wahren J
    Lancet; 1976 Dec; 2(7997):1213-6. PubMed ID: 63040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin primarily decreases plasma glucose not by gluconeogenesis suppression but by activating glucose utilization in a non-obese type 2 diabetes Goto-Kakizaki rats.
    Yoshida T; Okuno A; Tanaka J; Takahashi K; Nakashima R; Kanda S; Ogawa J; Hagisawa Y; Fujiwara T
    Eur J Pharmacol; 2009 Nov; 623(1-3):141-7. PubMed ID: 19765581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
    Basu R; Shah P; Basu A; Norby B; Dicke B; Chandramouli V; Cohen O; Landau BR; Rizza RA
    Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between exogenous insulin, endogenous insulin, and glucose in type 2 diabetes patients.
    Janukonyté J; Parkner T; Bruun NH; Lauritzen T; Christiansen JS; Laursen T
    Diabetes Technol Ther; 2015 May; 17(5):335-42. PubMed ID: 25785658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of lithium on plasma glucose, insulin and glucagon in normal and streptozotocin-diabetic rats: role of glucagon in the hyperglycaemic response.
    Hermida OG; Fontela T; Ghiglione M; Uttenthal LO
    Br J Pharmacol; 1994 Mar; 111(3):861-5. PubMed ID: 8019763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo effects of peroxovanadium compounds in BB rats.
    Yale JF; Vigeant C; Nardolillo C; Chu Q; Yu JZ; Shaver A; Posner BI
    Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):181-90. PubMed ID: 8927037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase of insulin sensitivity in diabetic rats received die-huang-wan, a herbal mixture used in Chinese traditional medicine.
    Wu YC; Hsu JH; Liu IM; Liou SS; Su HC; Cheng JT
    Acta Pharmacol Sin; 2002 Dec; 23(12):1181-7. PubMed ID: 12466058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihyperglycaemic action of diosmin, a citrus flavonoid, is induced through endogenous β-endorphin in type I-like diabetic rats.
    Hsu CC; Lin MH; Cheng JT; Wu MC
    Clin Exp Pharmacol Physiol; 2017 May; 44(5):549-555. PubMed ID: 28218955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electroacupuncture plus metformin lowers glucose levels and facilitates insulin sensitivity by activating MAPK in steroid-induced insulin-resistant rats.
    Liao HY; Sun MF; Lin JG; Chang SL; Lee YC
    Acupunct Med; 2015 Oct; 33(5):388-94. PubMed ID: 26025384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of metformin on insulin-stimulated tyrosine kinase activity of erythrocytes from obese women with normal glucose tolerance.
    Santos RF; Nomizo R; Bopsco A; Wajchenberg BL; Reaven GM; Azhar S
    Diabetes Metab; 1997 Apr; 23(2):143-8. PubMed ID: 9137903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.